Similar articles

• Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis.

  Gillis D, Yetiv N, Gdalevich M, Mimouni D, Ashkenazi I, Shpilberg O, Eldad A, Shemer J. Gillis D, et al. Vaccine. 2000 Jul 1;18(26):3005-10. doi: 10.1016/s0264-410x(00)00091-8. Vaccine. 2000. PMID: 10825603
• Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.

  Kurup A, San LM, Yew WS. Kurup A, et al. Clin Infect Dis. 1999 Jun;28(6):1324-5. doi: 10.1086/517784. Clin Infect Dis. 1999. PMID: 10451178 No abstract available.
• Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  [No authors listed] [No authors listed] MMWR Recomm Rep. 1996 Dec 27;45(RR-15):1-30. MMWR Recomm Rep. 1996. PMID: 9005304
• Hepatitis A: infection, detection, vaccination and immunity.

  van Hattum J, Chen XQ. van Hattum J, et al. Neth J Med. 1999 Sep;55(3):142-50. doi: 10.1016/s0300-2977(99)00073-x. Neth J Med. 1999. PMID: 10509073 Review. No abstract available.
• Clinical experience with an inactivated hepatitis A vaccine.

  Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, André FE. Clemens R, et al. J Infect Dis. 1995 Mar;171 Suppl 1:S44-9. doi: 10.1093/infdis/171.supplement_1.s44. J Infect Dis. 1995. PMID: 7876648 Review.